Amirhossein Sahebkar

Amirhossein Sahebkar is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.

Life Sahebkar completed a professional doctorate in pharmacy (Pharm.D.) in 2008 from Mashhad University of Medical Sciences. Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. He has completed fellowship careers in cardiometabolic diseases at the University of Western Australia, International Atherosclerosis Society, and Mashhad University of Medical Sciences. He is a fellow of the European Society of Cardiology and American College of Cardiology, and serves as the National Lead Investigator for the European Atherosclerosis Society. He is also an adjunct professor of universities outside of Iran. His primary research focus lies in basic and clinical studies aimed at developing novel therapeutic strategies for cardiometabolic diseases. He has been selected by Clarivate Analytics among global top 1% highly cited researches across different scientific fields.

Sahebkar is a Professor in the department of medical biotechnology at the Mashhad University of Medical Sciences. His research focuses on cardiovascular disease, atherosclerosis, and blood lipids. , of which 11 have been retracted. Five of those retractions are due to irregularities at the publisher Hindawi, where an investigation discovered more than 7000 articles with "systematic manipulation of the publication and peer-review process" and / or potentially connected to paper mills. Six further retractions are due to data and / or image irregularities.